HSPA5 and cancer: Results signify that co-administration of docetaxel and GRP78-siRNA to PC-3 cells elicits enhanced sensitivity of cancer cells to docetaxel both in vitro and in vivo, which might be a result of cell cycle arrest, apoptosis, and autophagy mediated by GRP78 knockdown [62].